Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 16

Clinical Trial Report

Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells

       
Total article views   HTML views PDF downloads Totals
2,622 Dovepress* 2,424+ 76 2,500
PubMed Central* 198 67 265
Totals 2,622 143 2,765
*Since 13 April 2023

View citations on PubMed Central and Google Scholar